ReviewCureus2026
Clinical Spectrum, Diagnostic Characteristics, and Treatment Outcomes of Neurobrucellosis: A Narrative Synthesis of Individual Patient Data From Global Literature.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurobrucellosis is a rare and serious complication of brucellosis that can present with a broad spectrum of neurological symptoms, making early detection challenging. The objective of this study was to comprehensively analyze data on neurobrucellosis to characterize its clinical manifestations, diagnostic approaches, and management strategies. This narrative review consolidates the available literature on all cases of neurobrucellosis published between inception and November 30, 2025, using the PubMed Central and Google Scholar databases. The data were stratified using predefined keyword combinations and Boolean operators. All case reports, case series, and original articles with confirmed cases of neurobrucellosis with intracranial involvement were included. After detailed scrutiny of the existing literature, a total of 23 articles were identified with data on 34 patients. Among the 34 patients, 22 (64.70%) were males, and 12 (35.29%) were females. The mean age was 35.7 ± 19.45 years. The most common presenting symptoms were headache in 23 (67.64%), fever in 16 (47.05%), and vomiting in 11 (32.35%) patients. On neurological examination, generalized weakness was present in eight (23.50%) patients, seizures in eight (23.50%) patients, and hearing loss in eight (23.50%) patients. The preferred imaging modality was MRI, which demonstrated hypointense multiloculated lesions on T1-weighted images in 11 (32.35%) patients and hyperintense lesions on T2-weighted images in eight (23.52%) patients. The most frequently involved brain region was the frontal lobe in 11 (32.35%) patients. Serological testing was confirmatory for diagnosis in 30 (88.23%) patients, with positivity on the serum agglutination test. CSF analysis showed elevated protein in 13 (38.23%) patients, leukocytosis in 10 (29.41%) patients, and culture positivity in four (11.76%) patients. The most common species was
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.